Hypofractionated radiation noninferior to conventional radiation for low-risk prostate cancer

A shorter, more intense radiation therapy schedule conferred comparable DFS as a conventional schedule among men with low-risk prostate cancer, according to results of stratified, parallel-group study. However, hypofractionated radiotherapy also increased risk for late grade 2 and 3 gastrointestinal and genitourinary adverse events.